Success Stories: A Chinese Assistant Director in Medicinal Chemistry with 3 Funding Grants, Gets NIW Approval and Retains Us for EB1-A for Our Diligent Team of Experts


Client’s Testimonial:

“Thank you for all the help with my case preparation. It has been a very pleasant experience.”

On August 25th, 2021, we received another EB-2 NIW (National Interest Waiver) approval for an Assistant Director in the Field of Medicinal Chemistry (Approval Notice).

General Field: Medicinal Chemistry

Position at the Time of Case Filing: Assistant Director

Country of Origin: China

State of Residence at the Time of Filing: Pennsylvania

Approval Notice Date: August 25th, 2021

Processing Time: 10 months, 20 days

Case Summary:

“Given the high incidence of tuberculosis and the growing frequency of drug resistance worldwide, it is imperative to support researchers who are advancing research related to the development of novel and effective drugs for treating such infectious diseases. [The client’s] outstanding study of two novel drug targets for tuberculosis is precisely the research that we need in the scientific community. As such the continuation of [client’s] research benefits the lives of countless people across the globe.”

“Drug resistance against the currently-used therapy has elevated the need for developing novel antimicrobial therapies which work via different pathways. [Client’s] medicinal chemistry research is of extreme value in this respect as he has established novel drugs to be tested for the treatment of malaria. He has developed novel chemical entities, which have demonstrated the ability to eliminate malaria parasites via a novel mode of action, thereby benefiting the patients who are resistant to current therapies. Therefore, [client’s] research is fundamental to the well-being of Americans, and he must be allowed to continue his studies that are providing functional solutions to increasing drug resistance against fatal diseases such as malaria.”

These are two quotations taken from the letters of support that our client, an assistant director in medicinal chemistry obtained at our suggestion. Both of which are ample proof to ascertain the global and local value of his research in the proposed field. He intends to continue to pursue research related to the development of drug candidates to treat infectious diseases, CNS disorders, and cancers, in particular, designing and synthesizing drug candidates for treating lung cancer, Parkinson’s disease, multiple myeloma, and COVID-19. His research advancing his proposed endeavor is of great importance because of its value to global treatment efforts of deadly diseases, including malaria and tuberculosis.

All of this information was gathered along with his publication count and citation records, as well as his review and funding experience to show that his expertise was of value to both academics and the government. We gathered that his research has resulted in 7 peer-reviewed journal articles (3 of them first-authored) and 1 book chapter and these publications have been cited a total of 134 times according to Google Scholar. He has also been regularly invited to conduct peer review for elite journals in the field making him complete 8 peer reviews to date.

On the other hand, due to its clear national importance, his research has in fact been supported with 3 separate funding from the National Institutes of Health (NIH) and the Army Medical Research and Materiel (Development) Command (USAMRDC). These organizations are all devoted to improving quality of life, treating illness and disease, and driving scientific discovery in the U.S.

Thus, our experts were able to help him prove beyond reasonable doubt that his work was of importance to the U.S. and should thus be allowed to continue on U.S. soil. We are grateful to him for retaining us for his EB1-A approval as well which we won for him recently in April 2022.

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 16,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Hundreds and Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our approved cases grew from 600 in 2013 to over 3,500 in 2019.

If you are interested in filing the green card, please send your CV to for our free evaluation. Our attorneys will email you back with the evaluation result within 24 hours.

Approval Notices:

Success Stories:


Free evaluation email:

Tel: 888.666.0969 (Toll Free)

To see more clients’ testimonials and approvals, please refer to:

Client's Testimonials

Approval Notices

To Learn More About Your Options CLICK HERE

Copyright © North America Immigration Law, All Rights Reserved.